Ultime notizie per Abivax (NASDAQ:ABVX) Azioni

ABIVAX SA-ADR

Abivax

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

<p>https://www.reuters.com/business/microsoft-launches-ai-based-copilot-mode-edge-browser-2025-07-28/#:~:text=July%2028%20(Reuters)%20%2D%20Microsoft,browsers%20and%20web%20search%20features.</p>


News

MSFT

"Microsoft Launches AI-Based Copilot Mode In Edge Browser; Copilot Mode Available For Free Starting July 28 Across Copilot Markets In Windows & Mac PCs For Limited Time; Starting July 28, Copilot In Edge Supports Natural Voice Navigation" - Reuters News

<p><strong>Meta Platforms</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is poised for a significant market focus on its expanding artificial intelligence initiatives, with increasing investments in AI talent and infrastructure signaling a strategic pivot.</p>
<p>The company&#8217;s aggressive push into advanced AI development is driving elevated revenue and earnings per share estimates for the upcoming quarters, despite the potential for rising operating expenses.</p>
<p><strong>Bank of America Securities</strong> analyst Justin Post, who reiterated a <a target="_blank" href="https://www.benzinga.com/quote/META/analyst-ratings" rel="noreferrer noopener">Buy rating</a> on Meta Platforms on Friday with a price forecast of $775, anticipates the company&#8217;s second-quarter earnings call will prominently feature its expanding AI initiatives.</p>
<p><strong><em>Also Read: <a target="_blank" href="https://www.benzinga.com/media/25/05/45680165/meta-hits-1-billion-monthly-ai-users-eyes-future-with-subscriptions" rel="noreferrer noopener">Meta Hits 1 Billion Monthly AI Users, Eyes Future With Subscriptions</a></em></strong></p>
<p>Post highlighted key developments such as Meta&#8217;s $14 billion investment in Scale AI, recent reports of delays concerning the Llama 4 model, and the formation of Meta&#8217;s dedicated Super Intelligence team, all of which underscore a deepening commitment to advanced AI development.</p>
<p>Meta Platforms is anticipated to report strong second-quarter revenue, which Post believes could alleviate concerns regarding its significant AI spending.</p>
<p>He further noted Meta&#8217;s aggressive recruitment of top-tier AI professionals, offering competitive compensation packages that could contribute to an uptick in operating expenses.</p>
<p>Post raised its second-quarter estimates, projecting revenue and GAAP EPS of $45.4 billion and $6.12, respectively, above Street estimates of $44.6 billion and $5.84. The analyst expects 8% growth in ad revenue, with foreign exchange providing a positive tailwind. He noted buy-side expectations landing between $45.5 and $46 billion, above the high end of Meta&#8217;s $42.5 and $45.5 billion guidance.</p>
<p>For the third quarter, Post forecasted $46.9 billion in revenue and $6.20 in EPS, ahead of the Street&#8217;s $45.9 billion and $5.91. The analyst expects Meta to guide within a $44.5-$47.5 billion range and see ad revenue continuing to benefit from AI-driven improvements like automated campaigns, CRM integration, and rising monetization across Threads, WhatsApp, and messaging.</p>
<p>Post noted that despite the AI hiring ramp, Meta has room within its 2025 expense guide of $113-$118 billion. The analyst estimated $27.8 billion in second-quarter expenses, with higher capex potentially driven by data center expansion and AI infrastructure needs.</p>
<p>Post also expects Meta to benefit from new tax laws and R&amp;D credits, possibly improving 2025 free cash flow by $4–5 billion.</p>
<p>The analyst noted Meta as one of the strongest long-term AI opportunities, with substantial revenue upside as AI tools integrate into the ad stack.</p>
<p>For full-year 2025, Post forecasted $190 billion in revenue and $26.83 in EPS (vs Street at $187 billion and $25.61). However, he cautioned that investor expectations are high heading into the print, especially with the stock up 22% year-to-date and trading at 24.5 times 2026 EPS.</p>
<p><strong>Price Action:</strong> META stock is trading higher by 0.55% to $716.50 at last check Monday.</p>
<p><strong><em>Read Next:</em></strong></p>
<ul class="wp-block-list">
<li><strong><em><a href="https://www.benzinga.com/markets/large-cap/25/07/46654942/how-amazons-price-war-is-crushing-temus-us-comeback" target="_blank" rel="noreferrer noopener">How Amazon&#8217;s Price War Is Crushing Temu&#8217;s US Comeback</a></em></strong></li>
</ul>
<p><em>Photo via Shutterstock</em></p>


Price Target

Reiteration

Analyst Ratings

Tech

Trading Ideas

Meta's Strong Revenues May Offset Concerns Over Soaring AI Investments: Analyst

<p><a href="https://www.theinformation.com/articles/microsofts-rivals-lean-ai-pry-away-longtime-customers" title="https://www.theinformation.com/articles/microsofts-rivals-lean-ai-pry-away-longtime-customers">https://www.theinformation.com/articles/microsofts-rivals-lean-ai-pry-away-longtime-customers</a></p>


AMZN

PLTR

'Defense Department Is Testing AI To Gain Leverage Over Providers Like Palantir' - The Information

<p>HC Wainwright &amp; Co.  analyst Swayampakula Ramakanth   maintains Celcuity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELC#NASDAQ">CELC</a>) with a Buy and raises the price target from $27 to $50.</p>


CELC

HC Wainwright & Co. Maintains Buy on Celcuity, Raises Price Target to $50

<h3>Gainers</h3>
<ul>
<li><strong>Connexa Sports Techs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYAI#NASDAQ">YYAI</a>) stock moved upwards by 26.2% to $3.97 during Monday's regular session. The market value of their outstanding shares is at $45.8 million. </li>
<li><strong>Betterware de Mexico SAPI</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWMX#NYSE">BWMX</a>) stock rose 19.98% to $13.15. The market value of their outstanding shares is at $408.9 million. As per the press release, Q2 earnings came out 2 days ago. </li>
<li><strong>Newegg Commerce</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) stock moved upwards by 19.32% to $40.94. The company's market cap stands at $668.2 million. </li>
<li><strong>Premium Catering (Hldgs)</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PC#NASDAQ">PC</a>) shares moved upwards by 17.47% to $6.99. The company's market cap stands at $10.5 million. </li>
<li><strong>Tilly's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) shares rose 16.75% to $2.09. The company's market cap stands at $53.9 million. </li>
<li><strong>Tron</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRON#NASDAQ">TRON</a>) stock increased by 14.89% to $11.03. The company's market cap stands at $171.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Aureus Greenway Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGH#NASDAQ">AGH</a>) shares fell 15.1% to $2.0 during Monday's regular session. The market value of their outstanding shares is at $32.6 million. </li>
<li><strong>YSX Tech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YSXT#NASDAQ">YSXT</a>) shares decreased by 12.6% to $3.61. The company's market cap stands at $96.7 million. </li>
<li><strong>Fitell</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) shares declined by 12.38% to $0.81. The company's market cap stands at $18.5 million. </li>
<li><strong>Genius Group</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares declined by 10.97% to $1.01. The market value of their outstanding shares is at $98.9 million. </li>
<li><strong>Worksport</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) shares decreased by 10.36% to $3.37. The company's market cap stands at $19.5 million. </li>
<li><strong>GoPro</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPRO#NASDAQ">GPRO</a>) stock decreased by 8.95% to $1.38. The market value of their outstanding shares is at $237.8 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Movers

BWMX

FTEL

GPRO

NEGG

TLYS

TRON

WKSP

YSXT

Connexa Sports Technologies Inc. - Common Stock

YYAI

12 Consumer Discretionary Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li><strong>Celcuity</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELC#NASDAQ">CELC</a>) stock increased by 186.2% to $39.41 during Monday's regular session. The company's market cap stands at $521.4 million. </li>
<li><strong>Scilex Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCLX#NASDAQ">SCLX</a>) shares rose 28.9% to $15.42. The market value of their outstanding shares is at $67.5 million. </li>
<li><strong>Abpro Hldgs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) shares moved upwards by 25.55% to $0.4. The market value of their outstanding shares is at $19.1 million. </li>
<li><strong>Adial Pharmaceuticals</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) stock moved upwards by 20.99% to $0.62. The company's market cap stands at $8.1 million. </li>
<li><strong>Hyperion DeFi</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYPD#NASDAQ">HYPD</a>) stock rose 17.59% to $9.05. The market value of their outstanding shares is at $39.3 million. </li>
<li><strong>X4 Pharmaceuticals</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) stock moved upwards by 17.3% to $2.13. The company's market cap stands at $13.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Adaptimmune Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) stock decreased by 66.2% to $0.12 during Monday's regular session. The company's market cap stands at $91.9 million. </li>
<li><strong>Can Fite Biofarma</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CANF#AMEX">CANF</a>) shares declined by 27.61% to $0.71. The company's market cap stands at $12.6 million. </li>
<li><strong>Calidi Biotherapeutics</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) stock decreased by 24.76% to $0.55. The company's market cap stands at $25.2 million. </li>
<li><strong>TAO Synergies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOX#NASDAQ">TAOX</a>) stock decreased by 17.37% to $6.95. The company's market cap stands at $19.5 million. </li>
<li><strong>Psyence Biomedical</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBM#NASDAQ">PBM</a>) stock declined by 16.52% to $9.6. The company's market cap stands at $8.2 million. </li>
<li><strong>Alterity Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) shares decreased by 14.66% to $5.59. The company's market cap stands at $96.9 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ADAP

ADIL

Alterity Therapeutics Limited - American Depositary Shares

ATHE

CANF

CLDI

HYPD

SCLX

TAOX

XFOR

12 Health Care Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li><strong>CEA Industries</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VAPE#NASDAQ">VAPE</a>) stock increased by 708.9% to $71.79 during Monday's regular session. The company's market cap stands at $7.4 million. </li>
<li><strong>VisionWave Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VWAV#NASDAQ">VWAV</a>) stock rose 281.27% to $8.96. The company's market cap stands at $33.5 million. </li>
<li><strong>Graphjet Technology</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) shares moved upwards by 35.45% to $0.13. The company's market cap stands at $14.6 million. </li>
<li><strong>Earlyworks Co</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELWS#NASDAQ">ELWS</a>) stock moved upwards by 29.2% to $2.79. The market value of their outstanding shares is at $6.5 million. </li>
<li><strong>Elong Power Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELPW#NASDAQ">ELPW</a>) shares rose 26.66% to $3.23. The company's market cap stands at $127.6 million. </li>
<li><strong>Stem</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEM#NYSE">STEM</a>) shares increased by 26.15% to $18.91. The company's market cap stands at $124.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Quhuo</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QH#NASDAQ">QH</a>) stock decreased by 89.5% to $0.14 during Monday's regular session. The market value of their outstanding shares is at $121.0 million. </li>
<li><strong>Sidus Space</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) stock fell 40.05% to $1.21. The company's market cap stands at $36.9 million. </li>
<li><strong>Lucas GC</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCL#NASDAQ">LGCL</a>) stock fell 27.76% to $0.6. The company's market cap stands at $92.6 million. </li>
<li><strong>YY Group Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYGH#NASDAQ">YYGH</a>) shares fell 18.0% to $2.78. The market value of their outstanding shares is at $129.6 million. </li>
<li><strong>Micropolis Hldgs</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) shares declined by 15.93% to $1.9. The company's market cap stands at $78.8 million. </li>
<li><strong>VCI Global</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCIG#NASDAQ">VCIG</a>) stock decreased by 14.67% to $1.05. The company's market cap stands at $5.1 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ELPW

ELWS

LGCL

MCRP

SIDU

STEM

VAPE

VCIG

VWAV

YYGH

12 Industrials Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li><strong>Nvni Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) stock moved upwards by 44.2% to $0.61 during Monday's regular session. The market value of their outstanding shares is at $38.7 million. </li>
<li><strong>Verb Technology Co</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) stock increased by 25.18% to $10.91. The market value of their outstanding shares is at $12.3 million. </li>
<li><strong>Upland Software</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPLD#NASDAQ">UPLD</a>) stock moved upwards by 24.35% to $2.4. The company's market cap stands at $54.9 million. </li>
<li><strong>SMX (Security Matters)</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) shares moved upwards by 24.3% to $2.64. The market value of their outstanding shares is at $8.0 million. </li>
<li><strong>Mercurity Fintech Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) stock moved upwards by 19.92% to $3.25. The market value of their outstanding shares is at $172.5 million. </li>
<li><strong>Zepp Health</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) stock increased by 18.5% to $13.19. The company's market cap stands at $667.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Sequans Communications</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQNS#NYSE">SQNS</a>) shares fell 24.0% to $1.5 during Monday's regular session. The market value of their outstanding shares is at $282.5 million. </li>
<li><strong>Mega Fortune Co</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGRT#NASDAQ">MGRT</a>) shares declined by 23.58% to $2.54. The market value of their outstanding shares is at $45.7 million. </li>
<li><strong>Roadzen</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDZN#NASDAQ">RDZN</a>) shares fell 18.96% to $1.24. The market value of their outstanding shares is at $113.6 million. </li>
<li><strong>Ostin Technology Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) stock declined by 14.06% to $0.1. The market value of their outstanding shares is at $15.9 million. </li>
<li><strong>Valens Semiconductor</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLN#NYSE">VLN</a>) shares fell 13.63% to $2.69. The market value of their outstanding shares is at $329.8 million. </li>
<li><strong>Banzai International</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) shares fell 13.18% to $3.36. The company's market cap stands at $9.5 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BNZI

MGRT

NVNI

RDZN

SQNS

UPLD

VERB

ZEPP

12 Information Technology Stocks Moving In Monday's Intraday Session

'Microsoft's Rivals Lean on AI to Pry Away Longtime Customers' - The Information

<p>O-I Glass (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OI#NYSE">OI</a>) is preparing to release its quarterly earnings on Tuesday, 2025-07-29. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect O-I Glass to report an <strong>earnings per share</strong> (EPS) of $0.41.</p>
<p>Investors in O-I Glass are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.16, which was followed by a 4.2% increase in the share price the next day.</p>
<p>Here's a look at O-I Glass's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.24</td>
<td>-0.08</td>
<td>0.04</td>
<td>0.44</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.40</td>
<td>-0.05</td>
<td>-0.04</td>
<td>0.44</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>4.0%</td>
<td>3.0%</td>
<td>-7.000000000000001%</td>
<td>15.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753722175_0.png" alt="eps graph" /></p>
<h3>Market Performance of O-I Glass's Stock</h3>
<p>Shares of O-I Glass were trading at $14.57 as of July 25. Over the last 52-week period, shares are up 23.84%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Insights on O-I Glass</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on O-I Glass.</p>
<p>Analysts have given O-I Glass a total of 8 ratings, with the consensus rating being Neutral. The average one-year price target is $16.5, indicating a potential 13.25% upside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of  and O-I Glass, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<h3>Summary of Peers Analysis</h3>
<p>In the peer analysis summary, key metrics for  and O-I Glass are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>O-I Glass</td>
<td>Neutral</td>
<td>-1.63%</td>
<td>$280M</td>
<td>-1.46%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>O-I Glass is positioned in the middle among its peers based on consensus rating. It ranks at the bottom for revenue growth, indicating a decline in revenue. The company also lags in gross profit compared to its peers. Additionally, O-I Glass has a lower return on equity, reflecting lower profitability relative to its industry counterparts.</p>
<h3>Get to Know O-I Glass Better</h3>
<p>O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.</p>
<h3>O-I Glass: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Negative Revenue Trend:</strong> Examining O-I Glass's financials over 3 months reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately <strong>-1.63%</strong> in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> O-I Glass's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>-1.02%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> O-I Glass's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>-1.46%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> O-I Glass's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-0.18%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>4.5</strong>, O-I Glass faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<p><a href="https://www.benzinga.com/quote/OI/earnings"><strong>To track all earnings releases for O-I Glass visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

Insights Ahead: O-I Glass's Quarterly Earnings

<p><strong>Lithia Motors</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAD#NYSE">LAD</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-07-29. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Lithia Motors will report an <strong>earnings per share</strong> (EPS) of $9.71. </p>
<p>The announcement from Lithia Motors is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings History Snapshot</h3>
<p>In the previous earnings release, the company missed EPS by $0.21, leading to a 4.99% increase in the share price the following trading session.</p>
<p>Here's a look at Lithia Motors's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>7.87</td>
<td>7.24</td>
<td>7.59</td>
<td>7.54</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>7.66</td>
<td>7.79</td>
<td>8.21</td>
<td>7.87</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>5.0%</td>
<td>-0.0%</td>
<td>0.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753722165_0.png" alt="eps graph" /></p>
<h3>Performance of Lithia Motors Shares</h3>
<p>Shares of Lithia Motors were trading at $312.94 as of July 25. Over the last 52-week period, shares are up 15.61%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Views on Lithia Motors</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Lithia Motors.</p>
<p>Analysts have provided Lithia Motors with 3 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $399.67, suggesting a potential 27.71% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Murphy USA, AutoNation and CarMax, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Murphy USA, with an average 1-year price target of $493.33, suggesting a potential 57.64% upside.</li>
<li>Analysts currently favor an Neutral trajectory for AutoNation, with an average 1-year price target of $228.33, suggesting a potential 27.04% downside.</li>
<li>Analysts currently favor an Outperform trajectory for CarMax, with an average 1-year price target of $82.9, suggesting a potential 73.51% downside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
<p>The peer analysis summary presents essential metrics for Murphy USA, AutoNation and CarMax, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lithia Motors</td>
<td>Buy</td>
<td>7.20%</td>
<td>$1.41B</td>
<td>3.12%</td>
</tr>
<tr>
<td>Murphy USA</td>
<td>Outperform</td>
<td>-6.57%</td>
<td>$483.60M</td>
<td>6.82%</td>
</tr>
<tr>
<td>AutoNation</td>
<td>Neutral</td>
<td>3.16%</td>
<td>$1.22B</td>
<td>7.22%</td>
</tr>
<tr>
<td>CarMax</td>
<td>Outperform</td>
<td>6.09%</td>
<td>$893.62M</td>
<td>3.36%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Lithia Motors ranks first in revenue growth among its peers. It has the highest gross profit margin. However, it has the lowest return on equity.</p>
<h3>Unveiling the Story Behind Lithia Motors</h3>
<p>Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.</p>
<h3>Lithia Motors: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Lithia Motors's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>7.2%</strong> as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Lithia Motors's net margin excels beyond industry benchmarks, reaching <strong>2.28%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Lithia Motors's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>3.12%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Lithia Motors's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.9%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>2.06</strong>.</p>
<p><a href="https://www.benzinga.com/quote/LAD/earnings"><strong>To track all earnings releases for Lithia Motors visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What's Next: Lithia Motors's Earnings Preview

<p>InvenTrust Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVT#NYSE">IVT</a>) will release its quarterly earnings report on Tuesday, 2025-07-29. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate InvenTrust Properties to report an <strong>earnings per share</strong> (EPS) of $0.23.</p>
<p>The market awaits InvenTrust Properties's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Historical Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS missed by $0.00, leading to a 1.15% increase in the share price on the subsequent day.</p>
<p>Here's a look at InvenTrust Properties's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.46</td>
<td>0.41</td>
<td>0.43</td>
<td>0.43</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.46</td>
<td>0.43</td>
<td>0.44</td>
<td>0.43</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>1.0%</td>
<td>2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753722156_0.png" alt="eps graph" /></p>
<h3>Market Performance of InvenTrust Properties's Stock</h3>
<p>Shares of InvenTrust Properties were trading at $27.54 as of July 25. Over the last 52-week period, shares are down 0.11%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/IVT/earnings"><strong>To track all earnings releases for InvenTrust Properties visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview For InvenTrust Properties

<p>Frontier Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FYBR#NASDAQ">FYBR</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-07-29. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Frontier Communications will report an <strong>earnings per share</strong> (EPS) of $-0.25.</p>
<p>Investors in Frontier Communications are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company missed EPS by $0.05, which was followed by a 0.03% drop in the share price the next day.</p>
<p>Here's a look at Frontier Communications's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.21</td>
<td>-0.16</td>
<td>-0.19</td>
<td>-0.14</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.26</td>
<td>-0.47</td>
<td>-0.33</td>
<td>-0.49</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>0.0%</td>
<td>0.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753722147_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Frontier Communications were trading at $36.67 as of July 25. Over the last 52-week period, shares are up 28.01%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/FYBR/earnings"><strong>To track all earnings releases for Frontier Communications visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


FYBR

Earnings Outlook For Frontier Communications

<p>DAT Freight &amp; Analytics has agreed to acquire the Convoy Platform from Flexport, adding best-in-class automation and digital freight-matching technology to its product portfolio.</p>
<p>The Convoy Platform provides freight brokers a powerful way to automate virtually every aspect of the freight transaction and connect with trusted trucking companies. It is an ideal complement to DAT One, DAT&#39;s flagship subscription-based load board, where nearly 700,000 loads are posted daily.</p>


Roper Technologies' DAT Freight & Analytics Agrees To Acquire Convoy Platform From Flexport; No Financial Terms Disclosed

<p>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) is gearing up to announce its quarterly earnings on Monday, 2025-05-05. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Fabrinet will report an <strong>earnings per share</strong> (EPS) of $2.47.</p>
<p>Fabrinet bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings Track Record</h3>
<p>In the previous earnings release, the company beat EPS by $0.12, leading to a 8.19% drop in the share price the following trading session.</p>
<p>Here's a look at Fabrinet's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2025</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.47</td>
<td>2.49</td>
<td>2.38</td>
<td>2.24</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.52</td>
<td>2.61</td>
<td>2.39</td>
<td>2.41</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-7.000000000000001%</td>
<td>-8.0%</td>
<td>-4.0%</td>
<td>16.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753722137_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Fabrinet were trading at $308.89 as of July 25. Over the last 52-week period, shares are up 47.16%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Views on Fabrinet</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Fabrinet.</p>
<p>The consensus rating for Fabrinet is Buy, derived from 6 analyst ratings. An average one-year price target of $267.83 implies a potential 13.29% downside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Sanmina, TTM Technologies and Flex, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Sanmina, with an average 1-year price target of $110.0, suggesting a potential 64.39% downside.</li>
<li>Analysts currently favor an Buy trajectory for TTM Technologies, with an average 1-year price target of $41.12, suggesting a potential 86.69% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Flex, with an average 1-year price target of $54.25, suggesting a potential 82.44% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>The peer analysis summary outlines pivotal metrics for Sanmina, TTM Technologies and Flex, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fabrinet</td>
<td>Buy</td>
<td>19.17%</td>
<td>$102.18M</td>
<td>4.34%</td>
</tr>
<tr>
<td>Sanmina</td>
<td>Neutral</td>
<td>8.15%</td>
<td>$176.24M</td>
<td>2.87%</td>
</tr>
<tr>
<td>TTM Technologies</td>
<td>Buy</td>
<td>13.78%</td>
<td>$130.97M</td>
<td>2.04%</td>
</tr>
<tr>
<td>Flex</td>
<td>Outperform</td>
<td>2.77%</td>
<td>$563M</td>
<td>3.81%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Fabrinet ranks highest in Revenue Growth among its peers. It also leads in Gross Profit. However, it has the lowest Return on Equity. Overall, Fabrinet is positioned favorably compared to its peers in terms of revenue growth and gross profit, but lags behind in return on equity.</p>
<h3>Delving into Fabrinet's Background</h3>
<p>Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.</p>
<h3>Fabrinet's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Revenue Growth:</strong> Fabrinet's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>19.17%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Fabrinet's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>9.32%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Fabrinet's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>4.34%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Fabrinet's ROA excels beyond industry benchmarks, reaching <strong>3.15%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Fabrinet's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.0</strong>.</p>
<p><a href="https://www.benzinga.com/quote/FN/earnings"><strong>To track all earnings releases for Fabrinet visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Uncovering Potential: Fabrinet's Earnings Preview

<p>Caesars Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-07-29. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Caesars Entertainment will report an <strong>earnings per share</strong> (EPS) of $0.08.</p>
<p>Investors in Caesars Entertainment are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company missed EPS by $0.36, which was followed by a 3.32% drop in the share price the next day.</p>
<p>Here's a look at Caesars Entertainment's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.18</td>
<td>-0.12</td>
<td>0.12</td>
<td>0.13</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.54</td>
<td>0.05</td>
<td>-0.04</td>
<td>0</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-3.0%</td>
<td>-1.0%</td>
<td>-8.0%</td>
<td>8.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753722127_0.png" alt="eps graph" /></p>
<h3>Caesars Entertainment Share Price Analysis</h3>
<p>Shares of Caesars Entertainment were trading at $29.56 as of July 25. Over the last 52-week period, shares are down 18.17%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<h3>Analysts' Take on Caesars Entertainment</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Caesars Entertainment.</p>
<p>With 9 analyst ratings, Caesars Entertainment has a consensus rating of Outperform. The average one-year price target is $40.11, indicating a potential 35.69% upside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Super Group (SGHC), Churchill Downs and Light &amp; Wonder, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Super Group (SGHC), with an average 1-year price target of $13.14, suggesting a potential 55.55% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Churchill Downs, with an average 1-year price target of $133.82, suggesting a potential 352.71% upside.</li>
<li>Analysts currently favor an Buy trajectory for Light &amp; Wonder, with an average 1-year price target of $108.5, suggesting a potential 267.05% upside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
<p>The peer analysis summary outlines pivotal metrics for Super Group (SGHC), Churchill Downs and Light &amp; Wonder, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Caesars Entertainment</td>
<td>Outperform</td>
<td>1.90%</td>
<td>$1.41B</td>
<td>-2.80%</td>
</tr>
<tr>
<td>Super Group (SGHC)</td>
<td>Buy</td>
<td>25.49%</td>
<td>$150M</td>
<td>9.63%</td>
</tr>
<tr>
<td>Churchill Downs</td>
<td>Outperform</td>
<td>4.91%</td>
<td>$392.10M</td>
<td>20.53%</td>
</tr>
<tr>
<td>Light &amp; Wonder</td>
<td>Buy</td>
<td>2.38%</td>
<td>$563M</td>
<td>13.06%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Caesars Entertainment ranks at the bottom for Revenue Growth and Gross Profit, while it ranks in the middle for Return on Equity.</p>
<h3>About Caesars Entertainment</h3>
<p>Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (49% of 2024 EBITDAR before corporate expenses) and regional (46%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.</p>
<h3>Unraveling the Financial Story of Caesars Entertainment</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Revenue Growth:</strong> Caesars Entertainment's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>1.9%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Caesars Entertainment's net margin excels beyond industry benchmarks, reaching <strong>-4.12%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Caesars Entertainment's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>-2.8%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Caesars Entertainment's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-0.35%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>6.19</strong>, Caesars Entertainment faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<p><a href="https://www.benzinga.com/quote/CZR/earnings"><strong>To track all earnings releases for Caesars Entertainment visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights Ahead: Caesars Entertainment's Quarterly Earnings

<p>Citizens (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIA#NYSE">CIA</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-08. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Citizens will report an <strong>earnings per share</strong> (EPS) of $0.05.</p>
<p>Anticipation surrounds Citizens's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>In the previous earnings release, the company missed EPS by $0.02, leading to a 4.01% increase in the share price the following trading session.</p>
<p>Here's a look at Citizens's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.05</td>
<td>0.09</td>
<td>0.08</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.03</td>
<td>0.07</td>
<td>0.05</td>
<td>0.08</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-6.0%</td>
<td>4.0%</td>
<td>-5.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753722115_0.png" alt="eps graph" /></p>
<h3>Market Performance of Citizens's Stock</h3>
<p>Shares of Citizens were trading at $4.09 as of July 25. Over the last 52-week period, shares are up 53.77%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/CIA/earnings"><strong>To track all earnings releases for Citizens visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Citizens's Earnings: A Preview

<p>Avis Budget Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-07-29. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Avis Budget Gr will report an <strong>earnings per share</strong> (EPS) of $1.91.</p>
<p>The announcement from Avis Budget Gr is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings Track Record</h3>
<p>During the last quarter, the company reported an EPS beat by $2.18, leading to a 0.59% increase in the share price on the subsequent day.</p>
<p>Here's a look at Avis Budget Gr's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-5.45</td>
<td>-0.79</td>
<td>8.18</td>
<td>2.66</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-3.27</td>
<td>14.51</td>
<td>6.65</td>
<td>0.41</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>-7.000000000000001%</td>
<td>11.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753722106_0.png" alt="eps graph" /></p>
<h3>Market Performance of Avis Budget Gr's Stock</h3>
<p>Shares of Avis Budget Gr were trading at $206.79 as of July 25. Over the last 52-week period, shares are up 109.57%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/CAR/earnings"><strong>To track all earnings releases for Avis Budget Gr visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What's Next: Avis Budget Gr's Earnings Preview

WYNN

CNBC Halftime Report Final Trades: Wynn Resorts, Taiwan Semiconductor Manufacturing, Phillips 66

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>KLA</strong>.</p>
<p>Looking at options history for KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) we detected 14 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 28% with bearish.</p>
<p>From the overall spotted trades, 8 are puts, for a total amount of $399,650 and 6, calls, for a total amount of $215,626.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $700.0 to $1380.0 for KLA over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in KLA's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to KLA's substantial trades, within a strike price spectrum from $700.0 to $1380.0 over the preceding 30 days.</p>
<h3>KLA Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753722099_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$79.4</td>
<td>$77.3</td>
<td>$77.3</td>
<td>$780.00</td>
<td>$54.1K</td>
<td align="right">2</td>
<td align="right">35</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$80.0</td>
<td>$77.3</td>
<td>$77.3</td>
<td>$780.00</td>
<td>$54.1K</td>
<td align="right">2</td>
<td align="right">14</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$80.0</td>
<td>$77.3</td>
<td>$77.3</td>
<td>$780.00</td>
<td>$54.1K</td>
<td align="right">2</td>
<td align="right">7</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$80.0</td>
<td>$77.3</td>
<td>$77.3</td>
<td>$780.00</td>
<td>$54.1K</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>KLAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$79.7</td>
<td>$77.1</td>
<td>$77.1</td>
<td>$780.00</td>
<td>$53.9K</td>
<td align="right">2</td>
<td align="right">28</td>
</tr>
</tbody>
</table>
</p>
<h3>About KLA</h3>
<p>KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market. It counts as top customers the largest chipmakers in the world, including TSMC and Samsung.</p>
<p>Following our analysis of the options activities associated with KLA, we pivot to a closer look at the company's own performance.</p>
<h3>KLA's Current Market Status</h3>
<ul>
<li>With a volume of 345,856, the price of KLAC is up 2.99% at $929.07. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 3 days.</li>
</ul>
<h3>Professional Analyst Ratings for KLA</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $916.2.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for KLA, targeting a price of $1035.<br />
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on KLA with a target price of $960.<br />
&#x2A; Reflecting concerns, an analyst from Wells Fargo lowers its rating to Equal-Weight with a new price target of $920.<br />
&#x2A; An analyst from Barclays has decided to maintain their Equal-Weight rating on KLA, which currently sits at a price target of $750.<br />
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on KLA, which currently sits at a price target of $916. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for KLA, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

KLAC

KLA Unusual Options Activity

Health Care

Press Releases

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones

Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis

Abivax Presents First Quarter 2025 Financial Results

Abivax Announces Results of its June 6, 2025 Annual General Meeting

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis

Abivax Announces Launch of Public Offering

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris

Abivax announces trading resumption of its ordinary shares on Euronext Paris

Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares

Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)

Comments

Abivax

Notizie

Ultime notizie per Abivax (NASDAQ:ABVX) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO